SEC Form 4 · accession 0001493152-15-005866
Targeted Medical Pharma, Inc. · TRGM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 24, 2015 | S | 8,580 | $0.015 | D | 2,646,668 | I | By Trust |
Table II — derivative securities
Remarks
1. This Form 4 is filed jointly by Kim Giffoni, Olena B. Giffoni and the Giffoni Family Trust dated September 26, 2008 ("Giffoni Family Trust"). The Giffoni Family Trust is a 10% owner of the Company and Mr. Giffoni & Ms. Giffoni may be deemed to be 10% owners of the Company. Mr. Giffoni is the Chief Executive Officer and a Director of the Company. 2. These securities are owned indirectly by Mr. Giffoni and Ms. Giffoni by virtue of their being co-Trustees of the Giffoni Family Trust. Mr. Giffoni and Ms. Giffoni share voting and dispositive control with respect to the securities owned by the Giffoni Family Trust. Mr. Giffoni and Ms. Giffoni disclaim beneficial ownership of any shares owned by the Giffoni Family Trust except to the extent of their pecuniary interest therein.